Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Slifstein

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Biological Psychiatry|August 4, 2010
Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]racloprideNina B L Urban, Lawrence S Kegeles, Mark Slifstein, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Biological Psychiatry|June 11, 2019
RETRACTED: Effects of L-DOPA Monotherapy on Psychomotor Speed and [<sup>11</sup>C]Raclopride Binding in High-Risk Older Adults With DepressionBret R Rutherford, Mark Slifstein, Chen Chen, et al.
Journal of Affective Disorders|March 25, 2023
Retraction notice to "Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study" [J. Affect. Disord. 265 (2020) 439-444]Bret R Rutherford, Jongwoo Choi, Mark Slifstein, et al.
Journal of Affective Disorders|February 25, 2020
Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot studyBret R Rutherford, Jongwoo Choi, Mark Slifstein, et al.
Psychopharmacology|November 29, 2002
Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652Justine M Kent, Jeremy D Coplan, Ilise Lombardo, et al.
Molecular Psychiatry|March 31, 2025
Cholinergic tone abnormalities and relationships with smoking severity in human cigarette smokers: exploratory positron emission tomography study using [<sup>18</sup>F]VATScott J Moeller, Jodi J Weinstein, Benjamin Varnas, et al.
Psychopharmacology|September 6, 2006
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635W Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2012
Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptorChristine A Parker, Roger N Gunn, Eugenii A Rabiner, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2010
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidoneW Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Biological Psychiatry|August 4, 2010
Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]racloprideNina B L Urban, Lawrence S Kegeles, Mark Slifstein, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Biological Psychiatry|June 11, 2019
RETRACTED: Effects of L-DOPA Monotherapy on Psychomotor Speed and [<sup>11</sup>C]Raclopride Binding in High-Risk Older Adults With DepressionBret R Rutherford, Mark Slifstein, Chen Chen, et al.
Journal of Affective Disorders|March 25, 2023
Retraction notice to "Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study" [J. Affect. Disord. 265 (2020) 439-444]Bret R Rutherford, Jongwoo Choi, Mark Slifstein, et al.
Journal of Affective Disorders|February 25, 2020
Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot studyBret R Rutherford, Jongwoo Choi, Mark Slifstein, et al.
Psychopharmacology|November 29, 2002
Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652Justine M Kent, Jeremy D Coplan, Ilise Lombardo, et al.
Molecular Psychiatry|March 31, 2025
Cholinergic tone abnormalities and relationships with smoking severity in human cigarette smokers: exploratory positron emission tomography study using [<sup>18</sup>F]VATScott J Moeller, Jodi J Weinstein, Benjamin Varnas, et al.
Psychopharmacology|September 6, 2006
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635W Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 7, 2012
Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptorChristine A Parker, Roger N Gunn, Eugenii A Rabiner, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2010
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidoneW Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Pageof 14